Evidence map›Paper›PMID 40943100›Full record

ArticleInternational journal of molecular sciences2025

Effects of Methotrexate and Tofacitinib on Mitochondrial Function and Oxidative Stress in Human Synovial Cells In Vitro.

Valentina Mihaylova, Desislav Tomov, Rositsa Karalilova, Zguro Batalov, Anastas Batalov, Victoria Sarafian, Maria Kazakova

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Valentina MihaylovaDepartment of Medical Biology, Medical University, Blvd. Vasil Aprilov 15A, 4000 Plovdiv, Bulgaria.ORCID 0000-0003-3845-2072
Desislav TomovResearch Institute, Medical University, 4002 Plovdiv, Bulgaria.ORCID 0000-0002-2028-9855
Rositsa KaralilovaDepartment of Propaedeutics of Internal Diseases, Medical University, 4002 Plovdiv, Bulgaria.
Zguro BatalovDepartment of Propaedeutics of Internal Diseases, Medical University, 4002 Plovdiv, Bulgaria.
Anastas BatalovDepartment of Propaedeutics of Internal Diseases, Medical University, 4002 Plovdiv, Bulgaria.ORCID 0000-0001-8857-0574
Victoria SarafianDepartment of Medical Biology, Medical University, Blvd. Vasil Aprilov 15A, 4000 Plovdiv, Bulgaria.ORCID 0000-0003-1501-0175
Maria KazakovaDepartment of Medical Biology, Medical University, Blvd. Vasil Aprilov 15A, 4000 Plovdiv, Bulgaria.

Funding

BBMRI D01-165/28.07.2022 and D01-371/15.12.2023Medical University Plovdiv NO 15-2025NextGeneration EU BG-RRP-2.004-0007-C01
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease affecting the synovium. Mitochondrial dysfunction is considered a critical factor in the pathogenesis of RA. The aim of the study was to determine the effect of methotrexate and tofacitinib on mitochondrial function and oxidative stress in an in vitro study on the model synovial cell line SW982. TNF-alpha-stimulated SW982 cells, as well as control untreated cells, were incubated with methotrexate and tofacitinib. A metabolic test was performed to assess mitochondrial function. The oxidative stress generated after the application of the therapeutics was determined by a chromatographic analysis. The results obtained showed an increase in ATP levels (

Indexed as

MethotrexateMitochondriaOxidative StressPiperidinesPyrimidinesSynovial MembraneSynoviocytesAdenosine TriphosphateAntirheumatic AgentsArthritis, RheumatoidCell LineHumansTumor Necrosis Factor-alphaAdenosine TriphosphateAntirheumatic AgentsMethotrexatePiperidinesPyrimidinestofacitinibTumor Necrosis Factor-alphaISOPGF2Amitochondrial functionoxidative stressSW982

Identifiers

PMID40943100
PMCPMC12428324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.